Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Explore cartoons & images using related keywords:

amino

anatomy

biology

body

bone

calcification

calcitonin

 care cell diagram disease formation fracture gene glucocorticoids health hormone human illustration inhibits lining medical medicine molecule osteoblast osteoclast osteoclasts osteocyte osteoporosis paracrine parathormone parathyrin parathyroid pathway physiological pth regulator resorption science sclerosteosis sclerostin secreted section skeleton sost steroids structure tissue treating vector

Sclerostin And Bone Formation. Osteoblasts, Osteocytes, And Osteoclasts Vector Illustration


Sclerostin and bone formation. osteoblasts, osteocytes, and osteoclasts Vector Illustration
Download
Designed by
Title
Sclerostin and bone formation. osteoblasts, osteocytes, and osteoclasts #197974220
Description

Sclerostin is secreted by osteocytes and inhibits bone formation. treating osteoporosis and fracture. Paracrine actions of osteoblasts, osteocytes, and osteoclasts

Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a
Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a
Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a
Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a
Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a

Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a
Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a

Rheumatoid arthritis
Murine sclerostin: target for osteoporosis treatment

Bone remodeling from resorption to new bone formation